Patent · US Expired

Osteocyte cell lines

US6358737B1 · kind B1 · utility

64Cited by
3References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 1998
Grant dateMar 19, 2002
Priority date
Expiry dateSep 11, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16222
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a method of producing osteocyte cell line in various stages of differentiation. Such cell line remains stable after more than 20 passages. The osteocyte has a stellate shape with dendritic processes and expresses high level of osteocalcin. More specifically, it provides a method of production for cultured osteocytes of various differentiation stages. Furthermore, it relates to osteocyte cell line, and more specifically cultured osteocyte. The invention also relates to a method for the production of monoclonal antibodies using such cultured osteocytes and further relates to hybridomas and monoclonal antibodies which recognize an osteocyte-specific antigen. Finally, the invention relates to a method of screening for modification factors and binding factors for osteocytes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.